|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Less: net earnings from discontinued operations | |||||
| Net earnings from continuing operations | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Amortization | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Gain on sale of property | |||||
| Loss from divestiture | |||||
| Loss from equity investments | |||||
| Russia exit and wind down costs | |||||
| Loss on extinguishment of debt | |||||
| Gain on investment in Vontier Corporation | |||||
| Gain on litigation resolution | |||||
| Change in certain assets and liabilities: | |||||
| Change in deferred income taxes | |||||
| Change in accounts receivable, net | |||||
| Change in inventories | |||||
| Change in trade accounts payable | |||||
| Change in prepaid expenses and other assets | |||||
| Change in accrued expenses and other liabilities | |||||
| Total operating cash provided by continuing operations | |||||
| Total operating cash provided by discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of property | |||||
| Cash infusion into divestiture | |||||
| Proceeds from sale of business | |||||
| Cash paid for acquisitions, net of cash received | |||||
| All other investing activities | |||||
| Total investing cash used in continuing operations | |||||
| Total investing cash used in discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net proceeds from (repayments of) commercial paper borrowings | |||||
| Repurchase of common shares | |||||
| Payment of dividends | |||||
| Proceeds from borrowings (maturities greater than 90 days), net of issuance costs | |||||
| Repayment of borrowings (maturities greater than 90 days) | |||||
| Payment of 0.875% convertible senior notes due 2022 | |||||
| Proceeds from Ralliant Dividend | |||||
| All other financing activities | |||||
| Total financing cash (used in) provided by continuing operations | |||||
| Total financing cash used in discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and equivalents | |||||
| Net change in cash and equivalents | |||||
| Beginning balance of cash and equivalents | |||||
| Ending balance of cash and equivalents | |||||
Loading...